China

In this round-up, China and the United Arab Emirates launch the phase three clinical trial for a coronavirus vaccine, the origin of nearly all the new infections in Beijing has been confirmed, and an adviser to the Donald Trump administration stirs the market with comments on the Sino-US trade deal.

Shenzhen Hepalink Pharmaceutical Group launched its Hong Kong IPO this week, targeting proceeds of HK$4.53bn ($585m).

Sino-Ocean Capital, an alternative investment and asset management business, leaned on its parent company Sino-Ocean Group Holdings to sell its first public dollar bond on Tuesday. But not every investor took comfort from the parent’s backing.

Chinese property company Agile Group Holdings’ new $500m bond tumbled in the secondary market on Wednesday after the firm took an aggressive approach to pricing.

The former head of JP Morgan’s China unit has joined US-based index provider MSCI to lead its Greater China client coverage.

Chinese property developers Ronshine China Holdings and Sichuan Languang Development Co returned to the market on Tuesday to reopen their dollar bonds. Both the borrowers priced their taps tightly, but saw their notes widen in the secondary market.

Commerzbank has appointed Tony Zhang as the country chief executive for China and the general manager of its Shanghai branch.

China’s ChiNext board, which focuses on innovative companies and start-ups, has started accepting listing applications as it kicks off a reform centred on a registration-based IPO system.

Fosun International pushed pricing aggressively for a new deal on Monday, but the $600m bond still surpassed its size expectations.

Qatar National Bank snapped up Rmb1.2bn ($170m) from a quick Formosa bond outing on Monday. Just a day after, the People’s Bank of China wrapped up one of its routine dim sum transactions.

Veolia Environnement, a French water, waste and energy management company, raised Rmb1.5bn ($212m) from a three year private placement Panda bond on Monday, pricing the deal inside of expectations.

Chinese company Genertec Universal Medical Group has launched a $600m dual-currency loan into syndication.